The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1306

..............................From my Ai friend. {not always reliable} According to the ASX reporting rules, a biotech company may not be required to report ongoing discussions with potential partners or buyers unless there is a binding agreement or a formal offer to consider..........................................

That's why listcos sign a HOA, LOI or MOU etc so an announcement of such development can be announced otherwise nothing to see as its all conjecture. Thats not to say that any agreements signed are binding.